Fortis Healthcare Limited on Friday, May 22, reported a 44.6% rise in consolidated net profit for the fourth quarter ended March 31, 2026, at ₹265.9 crore, supported by lower exceptional losses. Net profit stood at ₹183.9 crore in Q4FY25.Q4 revenue from operations rose 17.8% year-on-year to ₹2,364.7 crore from ₹2,007.2 crore, while EBITDA increased 22.2% to ₹532.3 crore from ₹435.5 crore. The EBITDA margin improved to 22.5% compared with 21.7% in the year-ago quarter.
The board recommended a final dividend of ₹1 per equity share of face value ₹10 each for FY26, subject to shareholder approval at the ensuing annual general meeting.
ALSO READ | RBL Bank open offer: Emirates NBD sets ₹282.38 price for 26% stakeShares of Fortis Healthcare Limited ended lower ahead of the company’s quarterly earnings announcement. The stock settled at ₹961.90 on the NSE, down ₹5.40 or 0.56%, from the previous close.
ALSO READ | RBI approves record ₹2.87 lakh crore dividend transfer to centre for FY26
(Edited by : Shoma Bhattacharjee)
